0001209191-22-021455.txt : 20220329
0001209191-22-021455.hdr.sgml : 20220329
20220329161255
ACCESSION NUMBER: 0001209191-22-021455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220328
FILED AS OF DATE: 20220329
DATE AS OF CHANGE: 20220329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thedinga Angela
CENTRAL INDEX KEY: 0001804588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 22780915
MAIL ADDRESS:
STREET 1: C/O ADVERUM BIOTECHNOLOGIES, INC.
STREET 2: 1035 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-28
0
0001787400
Nkarta, Inc.
NKTX
0001804588
Thedinga Angela
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
11.15
2022-03-28
4
A
0
32000
0.00
A
2032-03-27
Common Stock
32000
32000
D
This option is scheduled to vest and become exercisable in three substantially equal installments on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer.
/s/ Alicia Hager, as Attorney-in-Fact
2022-03-29